Cargando…
Bronchiectasis in the Last Five Years: New Developments
Bronchiectasis, a chronic lung disease characterised by cough and purulent sputum, recurrent infections, and airway damage, is associated with considerable morbidity and mortality. To date, treatment options have been limited to physiotherapy to clear sputum and antibiotics to treat acute infections...
Autores principales: | Khoo, Jun Keng, Venning, Victoria, Wong, Conroy, Jayaram, Lata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5184788/ https://www.ncbi.nlm.nih.gov/pubmed/27941638 http://dx.doi.org/10.3390/jcm5120115 |
Ejemplares similares
-
Neurological and Sleep Disturbances in Bronchiectasis
por: Phua, Chun Seng, et al.
Publicado: (2017) -
Sputum procalcitonin levels in patients admitted to hospital with acute exacerbations of bronchiectasis
por: Good, William, et al.
Publicado: (2020) -
The role of high-flow nasal therapy in bronchiectasis: a post hoc analysis
por: Good, William R., et al.
Publicado: (2021) -
Sputum procalcitonin: a potential biomarker in stable bronchiectasis
por: Good, William, et al.
Publicado: (2021) -
Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial
por: Jayaram, Lata, et al.
Publicado: (2022)